Back
ESC Professional Premium Access

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

Session: Prognosis and outcome in patients with atrial fibrillation
Topic: Rhythm Control, Cardioversion
Speaker: Doctor M. Kodali (Milwaukee, US)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Mouna Kodali

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)
0 follower

7 more presentations in this session

Cigarette smoking and structural brain deficits in patients with atrial fibrillation

Speaker: Mr R. Peter (Basel, CH)

Access
Abstract
Slides
Video
Thumbnail

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)

Speaker: Miss J. Choi (Seoul, KR)

Access
Abstract
Slides
Video
Thumbnail

The current and future total health care costs of atrial fibrillation

Speaker: Doctor R. Sandhu (Los Angeles, US)

Access
Abstract
Slides
Video
Thumbnail

Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices

Speaker: Doctor G. Peigh (Chicago, US)

Access
Abstract
Slides
Video
Thumbnail

Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Prognosis and outcome in patients with atrial fibrillation

Speakers: Doctor M. Kodali, Mr R. Peter, Miss J. Choi, Doctor R. Sandhu, Doctor G. Peigh...
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb